Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.
The spinal-cord counterpart to endomorphin-1, differing by a single aromatic residue.
Also known as: EM-2
Part of the Neuropeptides & signaling cluster
Overview
Endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) is an endogenous opioid tetrapeptide and a highly selective mu-opioid receptor agonist. It differs from endomorphin-1 by one residue and is more prevalent in the spinal cord. It is used as a research tool, and this page is educational only.
Source & context
Biological / chemical source: Mammalian central nervous system (endogenous), enriched in spinal cord
Primary research or clinical context: Endogenous neuropeptide and research tool in opioid pharmacology; not a Health Canada-authorized product
One-residue difference
Endomorphin-2 shares the Tyr-Pro-Phe-Phe-NH2 scaffold with endomorphin-1 but replaces the third-position tryptophan with phenylalanine. Both are amidated tetrapeptides with high mu-opioid selectivity, but endomorphin-2 is comparatively enriched in the spinal cord, making the pair a useful lesson in how small sequence changes shape distribution and pharmacology.
Research role and limits
Endomorphin-2 is used in laboratory studies of opioid receptor signalling and spinal analgesia in animal models. Like endomorphin-1 it is rapidly degraded and poorly brain-penetrant, so it remains a research probe rather than a medicine. This page is educational and makes no claim about pain or any medical use.
Structure & chemistry
Molecular identity & reference confidence
Source-supported reference
The four-residue chains agree. -NH2 records the C-terminal amide described in the IUPHAR snapshot and PubChem structure. Bare sequence arithmetic omits that modification.
- Molecular form
- Endomorphin-2, amidated tetrapeptide
- Species
- Not established by this molecular identity audit
- Termini (N / C)
- Not specified / Amide
Average reference mass · Molecular identity assessment: 2026-10-05
Reference policy updated: 2026-10-05
- IUPHAR/BPS source snapshot · 2026-10-01
- PubChem molecular record · 2026-10-01
- Molecular formula
- C32H37N5O5
- Average reference mass
- ≈ 571.7
- C-terminus
- Amide
- PubChem CID: 5311081
- IUPHAR ligand: 3668
- ChEMBL: CHEMBL333357
- CAS RN: 141801-26-5
- UNII: 3PH5M0466G
Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-10-01.
Endomorphin-2 — reconstitution calculator
Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.
Reference form: Endomorphin-2, amidated tetrapeptideAverage reference mass: 571.7 Da
Enter an amount to see the volume it corresponds to.
Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.
FAQ about Endomorphin-2
What is Endomorphin-2?+
Endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) is an endogenous opioid tetrapeptide and a highly selective mu-opioid receptor agonist. It differs from endomorphin-1 by one residue and is more prevalent in the spinal cord. It is used as a research tool, and this page is educational only.
What Canadian product status is recorded for Endomorphin-2?+
Canadian product status for Endomorphin-2 has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.
What is the typical length of Endomorphin-2?+
Endomorphin-2 is commonly described as approximately 4 amino acids (Endogenous opioid tetrapeptide).
Related peptides
References & further reading
- 1.Wang et al. (2024). Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice. Peptides
- 2.Tseng (2002). The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse. Jpn J Pharmacol
- 3.Huo et al. (2023). A novel endomorphin-2/salmon calcitonin hybrid peptide with enhancing anti-allodynic and anti-anxiety effects. Peptides
- 4.Narita et al. (2002). Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2. Jpn J Pharmacol
- 5.Liu et al. (2019). Effect of endomorphin-2 on orofacial pain induced by orthodontic tooth movement in rats. Eur J Oral Sci
- 6.Kruszynski et al. (2005). Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity. J Pept Res
- 7.Fujita et al. (2006). Inhibition by endomorphin-1 and endomorphin-2 of excitatory transmission in adult rat substantia gelatinosa neurons. Neuroscience
- 8.Kamei et al. (2000). The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. Eur J Pharmacol
- 9.PubMed — Endomorphins and related opioid peptides (review, 12481550)
- 10.Wikipedia — Endomorphin-2